Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 50
Filter
Add more filters










Publication year range
1.
J Neuroinflammation ; 15(1): 182, 2018 Jun 13.
Article in English | MEDLINE | ID: mdl-29898739

ABSTRACT

BACKGROUND: Alzheimer's disease is widely described since the discovery of histopathological lesions in Mrs. Auguste Deter in 1906. However to date, there is no effective treatment to deal with the many cellular and molecular alterations. The complexity is even higher with the growing evidence of involvement of the peripheral blood mononuclear cells (PBMCs). Indeed, monocytes and T cells are shown in the cerebral parenchyma of AD patients, and these cells grafted to the periphery are able to go through the blood-brain barrier (BBB) in transgenic mouse models. It is known that BBB is disrupted at a late stage of AD. Chemokines represent major regulators of the transmigration of PBMCs, but many data were obtained on AD animal models. No data are available on the role of AD BBB in a healthy brain parenchyma. Therefore, the purpose of this study was to analyze the longitudinal chemokine profile expression in a BBB model from AD transgenic mice versus wild-type (WT) mice. METHODS: A primary mouse BBB model was used with a luminal compartment either AD or WT and an abluminal compartment WT consisting of astrocytes and microglia. PBMCs were extracted by a ficoll gradient and incubated in the transwell with a direct contact with the luminal side, including the endothelial cells and pericytes. Then, the complete BBB model was incubated during 48 h, before supernatants and cell lysates were collected. Chemokines were quantified by X-MAP® luminex technology. RESULTS: Abluminal CX3CL1 production increased in 12-month-old AD BBB while CX3CL1 levels decreased in luminal lysates. CCL3 in luminal compartment increased with aging and was significantly different compared to AD BBB at 12 months. In addition, abluminal CCL2 in 12-month-old AD BBB greatly decreased compared to levels in WT BBB. On the contrary, no modification was observed for CCL4, CCL5, and CXCL10. CONCLUSION: These first findings highlighted the impact of AD luminal compartment on chemokine signature in a healthy brain parenchyma, suggesting new therapeutic or diagnostic approaches.


Subject(s)
Alzheimer Disease/pathology , Blood-Brain Barrier/metabolism , Chemokines/metabolism , Leukocytes, Mononuclear/metabolism , ATP Binding Cassette Transporter, Subfamily B, Member 1/metabolism , Alzheimer Disease/genetics , Amyloid beta-Protein Precursor/genetics , Animals , Blood-Brain Barrier/physiopathology , Capillary Permeability/genetics , Disease Models, Animal , Electric Impedance , Longitudinal Studies , Male , Mice , Mice, Transgenic , Mutation/genetics , Time Factors
2.
J Neuroinflammation ; 8: 72, 2011 Jun 23.
Article in English | MEDLINE | ID: mdl-21699726

ABSTRACT

BACKGROUND: Inflammation may be involved in the pathogenesis of Alzheimer's disease (AD). There has been little success with anti-inflammatory drugs in AD, while the promise of anti-inflammatory treatment is more evident in experimental models. A new anti-inflammatory strategy requires a better understanding of molecular mechanisms. Among the plethora of signaling pathways activated by ß-amyloid (Aß) peptides, the nuclear factor-kappa B (NF-κB) pathway could be an interesting target. In virus-infected cells, double-stranded RNA-dependent protein kinase (PKR) controls the NF-κB signaling pathway. It is well-known that PKR is activated in AD. This led us to study the effect of a specific inhibitor of PKR on the Aß42-induced inflammatory response in primary mixed murine co-cultures, allowing interactions between neurons, astrocytes and microglia. METHODS: Primary mixed murine co-cultures were prepared in three steps: a primary culture of astrocytes and microglia for 14 days, then a primary culture of neurons and astrocytes which were cultured with microglia purified from the first culture. Before exposure to Aß neurotoxicity (72 h), co-cultures were treated with compound C16, a specific inhibitor of PKR. Levels of tumor necrosis factor-α (TNFα), interleukin (IL)-1ß, and IL-6 were assessed by ELISA. Levels of PT451-PKR and activation of IκB, NF-κB and caspase-3 were assessed by western blotting. Apoptosis was also followed using annexin V-FITC immunostaining kit. Subcellular distribution of PT451-PKR was assessed by confocal immunofluorescence and morphological structure of cells by scanning electron microscopy. Data were analysed using one-way ANOVA followed by a Newman-Keuls' post hoc test RESULTS: In these co-cultures, PKR inhibition prevented Aß42-induced activation of IκB and NF-κB, strongly decreased production and release of tumor necrosis factor (TNFα) and interleukin (IL)-1ß, and limited apoptosis. CONCLUSION: In spite of the complexity of the innate immune response, PKR inhibition could be an interesting anti-inflammatory strategy in AD.


Subject(s)
Amyloid beta-Peptides/pharmacology , Inflammation/chemically induced , Inflammation/physiopathology , eIF-2 Kinase/antagonists & inhibitors , Alzheimer Disease/pathology , Alzheimer Disease/physiopathology , Animals , Apoptosis/drug effects , Astrocytes/cytology , Astrocytes/drug effects , Astrocytes/metabolism , Cells, Cultured , Coculture Techniques , Cytokines/metabolism , Humans , I-kappa B Kinase/metabolism , Imidazoles/pharmacology , Indoles/pharmacology , Mice , Mice, Inbred C57BL , Microglia/cytology , Microglia/drug effects , Microglia/metabolism , Microscopy, Electron, Scanning , NF-kappa B/metabolism , Neurons/cytology , Neurons/drug effects , Neurons/metabolism , Signal Transduction/drug effects , eIF-2 Kinase/metabolism
3.
J Pharmacol Exp Ther ; 332(2): 505-14, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19889791

ABSTRACT

Alzheimer's disease (AD), the most common form of dementia in the older people, is a multifactoral pathology, characterized by cognitive deficits, increase in cerebral deposition of the beta-amyloid (Abeta) peptide, neurofibrillary tangles, and neurodegeneration. Studies currently support a central role of neuroinflammation, through production of proinflammatory cytokines including excess tumor necrosis factor alpha (TNF-alpha) in the pathogenesis of AD, especially in Abeta-induced cognitive deficits. Imipramine, a tricyclic antidepressant, has potent anti-inflammatory and neuroprotective effects. This study investigates the effect of imipramine on alterations of long-term and short-term memories, TNF-alpha expression, and amyloid precursor protein (APP) processing induced by intracerebroventricular injection of Abeta25-35 in mice. Mice were treated with imipramine (10 mg/kg i.p. once a day for 13 days) from the day after the Abeta25-35 injection. Memory function was evaluated in the water-maze (days 10-14) and Y-maze (day 9) tests. TNF-alpha levels and APP processing were examined in the frontal cortex and the hippocampus (day 14). Imipramine significantly prevented memory deficits caused by Abeta25-35 in the water-maze and Y-maze tests, and inhibited the TNF-alpha increase in the frontal cortex. Moreover, imipramine decreased the elevated levels of Abeta both in frontal cortex and hippocampus with different modulations of APP and C-terminal fragments of APP. So, imipramine prevents memory impairment through its intrinsic property to inhibit TNF-alpha and Abeta accumulation and may represent a potential candidate for AD treatment.


Subject(s)
Alzheimer Disease/drug therapy , Imipramine/therapeutic use , Memory Disorders/drug therapy , Memory/drug effects , Neuroprotective Agents/therapeutic use , Tumor Necrosis Factor-alpha/metabolism , Amyloid beta-Peptides/administration & dosage , Amyloid beta-Peptides/metabolism , Amyloid beta-Protein Precursor/antagonists & inhibitors , Amyloid beta-Protein Precursor/metabolism , Animals , Cognition/drug effects , Disease Models, Animal , Frontal Lobe/drug effects , Frontal Lobe/metabolism , Hippocampus/drug effects , Hippocampus/metabolism , Imipramine/pharmacology , Injections, Intraventricular , Male , Memory Disorders/chemically induced , Mice , Neuroprotective Agents/pharmacology , Peptide Fragments/antagonists & inhibitors , Peptide Fragments/pharmacology
5.
Gen Comp Endocrinol ; 124(3): 333-42, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11742517

ABSTRACT

In the current study, the authors examined the effects of experimentally induced hypothyroidism on peripheral thyroid hormone metabolism and growth in two closely related tilapia species: the Nile tilapia (Oreochromis niloticus) and the slower growing black tilapia (Sarotherodon melanotheron). Hypothyroidism, induced by administration of 0.2% methimazole through the food, significantly decreased plasma T(3) and T(4) in both species. This decrease in circulating thyroid hormones was accompanied by an increase in hepatic type II deiodinase (D2) and a decrease in hepatic type III deiodinase (D3). Hepatic type I deiodinase (D1), which is barely expressed in euthyroid tilapia, was significantly upregulated during hypothyroidism. The changes in hepatic D1 and D2 enzyme activity were paralleled by changes in D1 and D2 mRNA levels, indicating pretranslational regulation. Hypothyroidism also resulted in severe growth retardation that was accompanied by an increase in condition factor. Because hyperthyroidism has been shown to decrease the condition factor, these results suggest that thyroid hormones play an essential role in the control of proportional body growth in fish. The authors conclude that (1) hepatic D1 expression is induced by hypothyroidism in tilapia, (2) the changes in hepatic iodothyronine deiodinases during hypothyroidism in tilapia are predominantly regulated at a pretranslational level, and (3) thyroid hormones are involved in the control of proportional body growth in fish.


Subject(s)
Gene Expression , Hypothyroidism/chemically induced , Hypothyroidism/enzymology , Iodide Peroxidase/genetics , Liver/enzymology , Tilapia/physiology , Amino Acid Sequence , Animals , Base Sequence , DNA, Complementary/chemistry , Iodide Peroxidase/chemistry , Methimazole , Molecular Sequence Data , Species Specificity , Thyroxine/blood , Thyroxine/physiology , Triiodothyronine/blood , Triiodothyronine/physiology
6.
Free Radic Biol Med ; 31(10): 1263-71, 2001 Nov 15.
Article in English | MEDLINE | ID: mdl-11705705

ABSTRACT

Plasmalogens are often considered as antioxidant molecules that protect cells from oxidative stress. Their vinyl ether bond could indeed be among the first targets for newly formed radicals. However, the long chain aldehydes released from plasmalogens were seldom studied and possible injurious or harmless effects were poorly examined. Thus, the sensitivity of the vinyl ether bond of plasmalogens was investigated in a cerebral cortex homogenate under UV irradiation- or Fe2+/ascorbate-induced peroxidation. Kinetics of aldehyde production was followed by gas chromatography/mass spectrometry. This confirmed that plasmalogens were highly sensitive to oxidative stress (70% cleavage after 90 min UV irradiation and 30% after 30 min of Fe2+/ascorbate). The aldehydes corresponding to sn-1 position 16:0, 18:0, or 18:1 were poorly detected. Conversely, oxidation of plasmalogens yielded preferentially 15:0, 17:0, and 17:1 aldehydes under UV and the alpha-hydroxyaldehydes 16:0-OH and 18:0-OH following a Fe2+/ascorbate oxidation. Kinetics showed that free aldehydes and above all free alpha-hydroxyaldehydes disappeared from the medium as soon as produced. Consequently, the behavior of these released aldehydes in the tissues has to be investigated in order to ascertain the protective effect of plasmalogens against oxidation.


Subject(s)
Aldehydes/metabolism , Cerebral Cortex/metabolism , Fatty Acids/metabolism , Oxidative Stress/physiology , Plasmalogens/metabolism , Animals , Gas Chromatography-Mass Spectrometry/methods , Hydroxyl Radical/metabolism , In Vitro Techniques , Kinetics , Male , Oxidation-Reduction , Rats , Rats, Wistar , Singlet Oxygen/metabolism
7.
Differentiation ; 68(2-3): 106-14, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11686232

ABSTRACT

The effect of different temperatures (4 degrees C and 12 degrees C) on myogenic regulatory factors (MyoD and myogenin) and myosin heavy chain (MyHC) expression was investigated in rainbow trout (Onchrhynchus mykiss) during early development. MyoD is first switched on at stage 14 [about 5 somites are formed (1/2 epiboly)] while myogenin mRNA is expressed at stage 15 [around 15 somites are visible (2/3 epiboly)] at both temperatures. Subsequently (up to at least stage 20), the most caudal somites exhibit less myogenin mRNA at 4 degrees C compared to 12 degrees C. At the eyed stage (stage 23-24), both myogenin mRNA and protein are present in greater amounts throughout all myotomes at the lower temperature, with mRNA levels in warmer (12 degrees C) embryos at 83% for MyoD and 72% for myogenin of the levels seen in 4 degrees C embryos. Conversely, however, at this same stage, fast-MyHC mRNA and protein are more abundant in 12 degrees C than in 4 degrees C embryos. This indicates relatively advanced muscle differentiation at the warmer temperature. At hatching, myogenin-positive cells are concentrated within the myosepta at both temperatures and they are also sparsely distributed in the myotome at 4 degrees C, but not at 12 degrees C. MyoD, myogenin, and MyHC levels provide an indication of differentiation of muscle cells. These findings suggest that myogenic regulatory factor expression is delayed but prolonged by the lowering of temperature.


Subject(s)
Cell Differentiation/physiology , Muscle, Skeletal/embryology , Myogenic Regulatory Factors/physiology , Oncorhynchus mykiss/embryology , Animals , Blotting, Northern , Embryo, Nonmammalian , Gene Expression Regulation, Developmental , Immunohistochemistry/methods , In Situ Hybridization/methods , MyoD Protein/physiology , Myogenin/physiology , Myosin Heavy Chains/physiology , Temperature
8.
Neurosci Lett ; 314(1-2): 82-6, 2001 Nov 13.
Article in English | MEDLINE | ID: mdl-11698152

ABSTRACT

The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) causes, via its metabolite MPP(+), damages of the nigrostriatal dopaminergic pathway, similar to those observed in Parkinson's disease. An intranigral injection of 10 microg MPP(+) in rat induced a decrease of about 30% of the neuronal dopamine transporter (DAT) activity 21 days after lesion. Based on the hypothesis that MPTP/MPP(+) neurotoxicity involves the nitric oxide (NO) production and/or an activation of poly(ADP-ribose) polymerase (PARP), we investigated the preventive effects of a treatment either with L-Name, a NO synthase (NOS) inhibitor or 3-aminobenzamide, a PARP inhibitor on the reduction of dopamine uptake induced by MPP(+). Rats received a daily injection i.p. of 50 mg/kg L-Name or 10 mg/kg 3-aminobenzamide 3 days before and during 21 days after the MPP(+) lesion. The results showed that inhibitors of NOS and PARP did not prevent the alteration of DAT activity induced by 10 microg MPP(+), indicating that NO and PARP were not involved in the biochemical cascade leading to the inhibition of rat DAT activity by MPP(+) in our experimental conditions.


Subject(s)
Enzyme Inhibitors/pharmacology , Membrane Glycoproteins , Membrane Transport Modulators , Membrane Transport Proteins/antagonists & inhibitors , Nerve Tissue Proteins , Neurons/drug effects , Nitric Oxide Synthase/antagonists & inhibitors , Parkinsonian Disorders/drug therapy , Poly Adenosine Diphosphate Ribose/antagonists & inhibitors , Substantia Nigra/drug effects , 1-Methyl-4-phenylpyridinium/pharmacology , Animals , Dopamine/metabolism , Dopamine/pharmacokinetics , Dopamine Plasma Membrane Transport Proteins , Drug Interactions/physiology , Male , Membrane Transport Proteins/metabolism , Neurons/enzymology , Neuroprotective Agents/pharmacology , Nitric Oxide/metabolism , Nitric Oxide Synthase/metabolism , Parkinsonian Disorders/enzymology , Parkinsonian Disorders/physiopathology , Poly Adenosine Diphosphate Ribose/metabolism , Presynaptic Terminals/drug effects , Presynaptic Terminals/metabolism , Radioligand Assay , Rats , Rats, Wistar , Substantia Nigra/enzymology , Substantia Nigra/physiopathology , Synaptosomes/drug effects , Synaptosomes/metabolism , Tritium
9.
J Exp Biol ; 204(Pt 16): 2763-71, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11683432

ABSTRACT

The influence of changes in environmental temperature on the mRNA levels of myogenic regulatory factors (MRFs), i.e. MyoD and myogenin, as well as myosin heavy chain (MyHC) were studied during early larval development in rainbow trout and sea bass. Phosphoimager analysis of northern blots indicated that there is an optimum temperature for the RNA transcript levels of MRF and MyHC RNA in trout and in sea bass larvae. In the trout strain studied, the highest concentration for MRF and MyHC transcripts was found at 8 degrees C rather than 4 degrees C or 20 degrees C. In European sea bass, the highest concentrations of MRF and MyHC mRNA were observed at 15-20 degrees C rather than 13 degrees C. Raising sea bass larvae at 15 degrees C was associated with higher MyHC gene expression as well as a trend towards an increase in total muscle fibre number and higher growth rates after transfer at ambient temperature. Results suggest that mRNA levels of MRF and MyHC can be used to optimise early development. An experiment in which the temperature was changed illustrates the consequence of precise temporal expression of MRF genes in specifying muscle fibre number at critical stages during early development.


Subject(s)
Bass/growth & development , Muscle Development/genetics , MyoD Protein/genetics , Myogenin/genetics , Oncorhynchus mykiss/growth & development , Temperature , Animals , Larva/growth & development , Muscle Development/physiology , Muscle Fibers, Skeletal , Myosin Heavy Chains/genetics , Polymerase Chain Reaction , RNA, Messenger/analysis
10.
J Exp Biol ; 204(Pt 12): 2097-101, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11441051

ABSTRACT

The axial muscle of most teleost species consists of a deep bulk of fast-contracting white fibres and a superficial strip of slow-contracting red fibres. To investigate the embryological development of fast and slow muscle in trout embryos, we carried out single and double in situ hybridisation with fast and slow myosin heavy chain (MyHC)-isoform-specific riboprobes. This showed that the slow-MyHC-positive cells originate in a region of the somite close to the notochord. As the somite matures in a rostrocaudal progression, the slow-MyHC-positive cells appear to migrate radially away from the notochord to the lateral surface of the myotome, where they form the superficial strip of slow muscle. Surprisingly, the expression pattern of the fast MyHC showed that the differentiation of fast muscle commences in the medial domain of the somite before the differentiation and migration of the slow muscle precursors. Later, as the differentiation of fast muscle progressively spreads from the inside to the outside of the myotome, slow-MyHC-expressing cells become visible medially. Our observations that the initial differentiation of fast muscle takes place in proximity to axial structures and occurs before the differentiation and migration of slow muscle progenitors are not in accord with the pattern of muscle formation in teleosts previously described in the zebrafish Danio rerio, which is often used as the model organism in fishes.


Subject(s)
Muscle Fibers, Fast-Twitch/cytology , Muscle Fibers, Fast-Twitch/metabolism , Myosin Heavy Chains/genetics , Oncorhynchus mykiss/embryology , Oncorhynchus mykiss/genetics , Amino Acid Sequence , Animals , Base Sequence , Cell Differentiation , Cell Movement , DNA Primers/genetics , In Situ Hybridization , Molecular Sequence Data , Sequence Homology, Amino Acid , Somites/cytology , Somites/metabolism
12.
Aquat Toxicol ; 53(3-4): 247-63, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11408083

ABSTRACT

Muscle satellite cells from rainbow trout were exposed in vitro to increasing concentrations of different xenobiotics: copper, dichloroaniline, prochloraz, nonyl-phenol polyethexylate. Mortality and proliferation rate were measured by Hoechst binding and BrdU incorporation. Dose dependent effect of copper on survival and proliferation was observed with an EC50 at 100 microM. A dose dependent effect of nonyl-phenol diethoxylate was observed on survival with an EC50 at 100 microM. This was associated with a biphasic effect on proliferation rate observed both for nonyl-phenol di and poly-ethoxylate: a stimulation of proliferation at low concentration and an inhibition proliferation at large concentration. These effects were related to the inhibition of cells adhesion through the detergent capacity of nonyl-phenol polyethoxylate. The effects of prochloraze and dichloroaniline on cells mortality (EC 50 > 500 microM) and proliferation rate (LOEC: 100 microM) were limited. Whole fish growth, muscle fibre size distribution and satellite cells survival and proliferation were measured on rainbow trout (60-80 g BW) exposed to two concentrations of prochloraze (10 and 100 microg/ml) or nonyl phenol diethoxylate IGEPAL 210 (100 and 400 microg/ml) during 14 and 10 days exposure, respectively. Muscle fibre size distribution and satellite cells proliferation were affected by prochloraz exposure in vivo and this could be related to the alteration in fish feeding status. The exposure to IGEPAL 210 affected the number of satellite cells extracted and induce a biphasic effect on satellite cells proliferation similar to that observed in vivo. The combined exposure to IGEPAL 210 and prochloraze revealed additive effects of these two compounds. The in vivo and in vitro comparison demonstrated that in vitro satellite cells system could be used as a valuable tool to test the effects of pollutants.


Subject(s)
Environmental Pollutants/toxicity , Muscles/drug effects , Aniline Compounds/toxicity , Animals , Cell Division/drug effects , Cell Survival/drug effects , Cells, Cultured , Copper/toxicity , Dose-Response Relationship, Drug , Imidazoles/toxicity , Muscles/cytology , Oncorhynchus mykiss , Phenols/toxicity , Polyethylene Glycols/toxicity
13.
Arch Toxicol ; 74(11): 695-701, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11218046

ABSTRACT

Astrocytes are known to play a key role in buffering extracellular pH variations and, in addition, they are particularly resistant to oxidative stress and subsequent lipid peroxidation. This great resistance may be ascribed to the presence of high concentrations of certain antioxidants, but another explanation may be the presence of a high quantity of plasmalogens, which are a special group of glycerophospholipids characterized by a vinyl ether bond instead of an ester bond in the sn-1 position of the glycerol backbone. Plasmalogens are sensitive to free radical attack and acidity, and numerous works have supported the hypothesis that they may be antioxidant molecules that protect cells from oxidative stress. The aim of this work was to investigate, on astrocytes in lactic acid-induced oxidative stress (pH 5.5), the behavior of phospholipids and, in particular, plasmalogens. Two main techniques, based on the susceptibility of the vinyl ether bond to hydrolysis, were employed in this study to measure plasmalogen levels. In both cases, the sn-1 vinyl ether linkage was cleaved using mercuric chloride, producing a lysophospholipid that was assessed by phosphorus measurement or using HCl treatment, producing a long-chain fatty aldehyde assayed by gas chromatography/mass spectrometry. On astrocytes in culture, only plasmenylethanolamine (PlmEtn) was evidenced, representing 40% of glycerophosphoethanolamine lipids. When astrocytes were incubated with lactic acid, no modification in the amount of PlmEtn was seen. Furthermore, free aldehydes and aldehydes corresponding to the quantity of intact plasmalogens were similar to those observed on controls. In addition, the constancy of two lipid peroxidation markers, thiobarbituric acid reactive substances and polyunsaturated fatty acids, was clear evidence of the resistance of these cells in lactic acid conditions. In conclusion, our results fail to demonstrate a major role of plasmalogens in the resistance of astrocytes in lactic acid-induced oxidative stress.


Subject(s)
Acidosis, Lactic/metabolism , Antioxidants/metabolism , Astrocytes/metabolism , Oxidative Stress/physiology , Plasmalogens/physiology , Acidosis, Lactic/chemically induced , Animals , Animals, Newborn , Astrocytes/drug effects , Cells, Cultured , Cerebral Cortex/cytology , Fatty Acids/analysis , Gas Chromatography-Mass Spectrometry , Lactic Acid/pharmacology , Lipid Peroxidation/drug effects , Oxidative Stress/drug effects , Plasmalogens/analysis , Plasmalogens/classification , Rats , Rats, Sprague-Dawley , Thiobarbituric Acid Reactive Substances/metabolism
14.
Neurochem Int ; 38(3): 243-8, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11099783

ABSTRACT

Previous studies have shown that dopamine (DA) uptake was decreased after preincubation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) or 1-methyl-4-phenylpyridinium (MPP(+)) in in vitro slice and synaptosome models. The present study, conducted with and without preincubation, attempted to determine whether inhibition results from a direct effect of neurotoxins on neuronal DA transporter or from an alteration of the transporter secondary to other toxic events. DA uptake was inhibited about 50% in the presence of MPTP+O(2) or MPP(+) (0.1, 1 and 5 mM) in rat striatal slices and synaptosomes. Such inhibition was obtained in synaptosomes preincubated for 150 min with MPP(+) and then washed. Inhibition of DA uptake was lower in slices preincubated with MPTP (5 mM)+O(2) and then washed (30%). Experiments in synaptosomes prepared from slices preincubated with MPTP or MPP(+) showed greater inhibition of DA uptake with MPTP. The results suggest that the inhibition of DA uptake in vitro by MPTP or MPP(+) results initially from a direct effect on the transporter during its penetration in nerve endings and subsequently from a transporter alteration related to toxic events. Thus, the preincubation of striatal slices followed by DA uptake measurement in synaptosomes would appear to be a good in vitro model for studying the dopaminergic toxicity of MPTP.


Subject(s)
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine/pharmacology , Corpus Striatum/drug effects , Corpus Striatum/metabolism , Dopamine/metabolism , Membrane Glycoproteins , Membrane Transport Proteins , Nerve Tissue Proteins , Synaptosomes/metabolism , 1-Methyl-4-phenylpyridinium/toxicity , Animals , Carrier Proteins/metabolism , Corpus Striatum/chemistry , Dopamine/pharmacokinetics , Dopamine Agents/pharmacology , Dopamine Plasma Membrane Transport Proteins , Dose-Response Relationship, Drug , In Vitro Techniques , Male , Models, Biological , Rats , Rats, Wistar , Synaptosomes/drug effects
15.
Cell Tissue Res ; 301(3): 459-63, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10994791

ABSTRACT

The effects of short-term fasting and refeeding were studied on satellite cells extracted from white epaxial muscle of juvenile rainbow trout (1-3 g body weight). In vitro changes in the proliferation of satellite cells were analyzed using bromodeoxyuridine (BrdU) incorporation over a 24-h period. Proliferation in fed control fish was characterized by an initial basal proliferation rate of 5-10% BrdU-labeled nuclei x day(-1), followed by an exponential increase at a rate of +18-20% x day(-1), up to a maximum of 60-70% BrdU-labeled nuclei x day(-1). Characteristics of satellite cells extracted from starved fish, namely extraction yield, morphology, and proliferation, were different from those of fed fish. Fasting (8-10 days) completely suppressed initial proliferation of satellite cells in vitro over a period of 4 days. After this delay, proliferation resumed and changes in proliferation rates over time were similar to those of the control group. In fish fed for 4 days after an 8-day fast, the initial proliferation rate and the changes in proliferation rates over time were completely restored. These findings demonstrate that satellite cells express different behavior depending on feeding status, which could be due to the presence of different satellite cell populations.


Subject(s)
Fasting/physiology , Muscle Fibers, Skeletal/cytology , Muscle, Skeletal/cytology , Oncorhynchus mykiss/physiology , Age Factors , Animals , Body Weight , Cell Division/physiology , Cells, Cultured , In Vitro Techniques , Muscle Development , Muscle Fibers, Skeletal/physiology , Muscle, Skeletal/growth & development
16.
J Exp Zool ; 286(4): 379-89, 2000 Mar 01.
Article in English | MEDLINE | ID: mdl-10684561

ABSTRACT

Embryonic muscle development was studied in rainbow trout (Oncorhynchus mykiss) at low and high temperature using scanning electron microscopy (SEM) and immunohistology. Somite development was described starting at stage 16 (Vernier JM. 1969. Ann Embryol Morphogen 4:495-520) for both temperatures, with special interest in their shape and size. Muscle differentiation, associated with somite growth, is characterized by a larger increase in height compared to width and by acquisition of a chevron shape. Thin structures such as striation, sarcomeres, and myofibrils within muscle cells and myotubes were observed starting at the eyed stage (stage 24). Immunohistological analyses showed appearance of embryonic fast myosin at stage 20 in the deep part of the somite. The area where myosin was expressed extended in the somite throughout embryonic development and the presence of myosin was observed in the entire somite at hatching (stage 30). Slow myosin was expressed in a monolayer of superficial cells at the eyed stage and during the entire embryonic development. Then it was expressed in a few layers of cells located in the red muscle area. These results suggest that muscle differentiation, characterized by myosin expression, is engaged at stage 20. Myogenesis starts in the deep part of the somite, near the notochord and progresses laterally to cover the complete somite at hatching when the somite is composed of muscle fibres exhibiting a high degree of maturity. No significant difference was observed in terms of muscular development between low- and high-temperature conditions. J. Exp. Zool. 286:379-389, 2000.


Subject(s)
Muscle, Skeletal/embryology , Oncorhynchus mykiss/embryology , Animals , Embryo, Nonmammalian/embryology , Immunohistochemistry , Microscopy, Electron, Scanning , Muscle Fibers, Skeletal/immunology , Muscle Fibers, Skeletal/ultrastructure , Muscle, Skeletal/immunology , Muscle, Skeletal/ultrastructure
17.
Eur J Med Chem ; 34(11): 991-996, 1999 Nov 01.
Article in English | MEDLINE | ID: mdl-10889322

ABSTRACT

The synthesis and in vitro antioxidant activity of 17 new tetraarylpyrroles are investigated by 2 tests highly documented in the literature: capability to prevent Fe(2+)-induced lipid peroxidation on microsomes, which is a membrane preparation rich in polyunsaturated fatty acids, and direct scavenging effect on a stable free radical, 1,l-diphenyl-2-picryl-hydrazyl (DPPH). For the Fe(2+)-induced microsomal lipid peroxidation system, the results show that molecules which possess 2-pyrazinyl or 2-pyridyl in the 3- and 4-positions on the pyrrole ring are the most efficient. Introduction of methoxy groups on the phenyl ring in the 2- and 5-positions increases the effects but the higher activity is obtained with 2-furyl or 2-thienyl. The only compounds which possess a direct scavenger effect on trapping the stable free radical DPPH are those which have 2-pyridyl in the 3- and 4-positions and 2-furyl or 2-thienyl in the 2- and 5-positions.

18.
Neurosci Lett ; 277(2): 91-4, 1999 Dec 24.
Article in English | MEDLINE | ID: mdl-10624817

ABSTRACT

Previous experiments reported that an incubation of striatal synaptosomes with 4-hydroxynonenal (4-HNE) resulted in an inhibition of dopamine (DA) uptake and Na+/K+ adenosine triphosphate (ATPase) activity. The present work investigated whether theses inhibitions are related to a 4-HNE binding to the DA transporter (DAT) and the Na+/K+ ATPase. The number of specific [125I]-PE21 binding sites on the DAT was significantly reduced after incubation with 4-HNE. The Na+/K+ ATPase activity decrease induced by 4-HNE was partially reversed, in a dose-dependent manner, by veratridine, a pump stimulator agent. Our previous data (Morel, P., Tallineau, C., Pontcharraud, R., Piriou, A. and Huguet, F., Effects of 4-hydroxynonenal, a lipid peroxidation product, on dopamine transport and Na+/K+ ATPase in rat striatal synaptosomes. Neurochem. Int., 33 (1999) 531-540) combining with the data observed in this study suggest that changes in DA uptake in striatal synaptosomes are directly related to 4-HNE binding to the DAT, whereas the decrease in Na+/K+ ATPase activity resulted only partially from 4-HNE binding to the pump and is mainly secondary to membrane lipid disruption.


Subject(s)
Adenosine Triphosphatases/drug effects , Aldehyde Dehydrogenase/antagonists & inhibitors , Aldehydes/pharmacology , Carrier Proteins/drug effects , Cation Transport Proteins , Membrane Glycoproteins , Membrane Transport Proteins , Nerve Tissue Proteins , Synaptosomes/drug effects , Adenosine Triphosphatases/metabolism , Animals , Carrier Proteins/metabolism , Corpus Striatum/drug effects , Corpus Striatum/metabolism , Dopamine Plasma Membrane Transport Proteins , Male , Rats , Rats, Wistar , Sodium-Potassium-Exchanging ATPase , Synaptosomes/metabolism , Veratridine/pharmacology
19.
Neurosci Lett ; 255(3): 139-42, 1998 Oct 23.
Article in English | MEDLINE | ID: mdl-9832192

ABSTRACT

Incubation of rat striatal slices induced a large decrease (about 50%) of DA uptake and a slight desialylation of polysialogangliosides (GT1b, GD1b, GD1a) with an increase of monosialogangliosides (GM1). Moreover, a pretreatment of slices by exogenous added neuraminidase of Vibrio cholerae did not modify DA uptake, although the pattern of gangliosides was modified and there was considerable loss (about 45%) of sialic acid in gangliosides and glycoproteins. It was verified that neuraminidase activity occured in synaptic membrane. Thus, DA uptake was apparently not altered by desialylation of plasma membrane carbohydrate conjugates.


Subject(s)
Carbohydrate Metabolism , Cell Membrane/metabolism , Corpus Striatum/metabolism , Dopamine/pharmacokinetics , N-Acetylneuraminic Acid/metabolism , Animals , Corpus Striatum/drug effects , G(M1) Ganglioside/metabolism , Gangliosides/metabolism , Glycoproteins/metabolism , In Vitro Techniques , Male , Neuraminidase/analysis , Neuraminidase/pharmacology , Osmolar Concentration , Rats , Rats, Wistar , Tritium , Vibrio cholerae/chemistry
20.
Neurosci Res ; 32(2): 171-9, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9858024

ABSTRACT

Ascorbic acid is frequently added in the incubation medium to prevent oxidation of dopamine (DA) during uptake assays. However, a preliminary study showed that the presence of ascorbic acid induced a decrease of DA uptake after prolonged incubation. The purpose of this study was to determine the mechanism underlying ascorbic acid-induced alterations of DA uptake in rat striatal synaptosomes. In this context, the effects of physiological concentrations of ascorbic acid (100-500 microM) on DA uptake and Na+/K+ ATPase activity (which is essential for DA transporter function) were assessed in synaptosomes before and after incubation at 37 degrees C. The capacity of synaptosomes to take up DA was significantly decreased after incubation owing to a reduction in DA transporters (but with no modification of their affinity for DA). This partial inhibition was associated with a decrease of Na+/K+ ATPase activity, a production of thiobarbituric acid reactive substances (TBARS) and malonaldehyde (MDA), and a loss of sulfhydryl group content. Addition of Trolox C to the medium prevented the reduction of DA uptake, the inhibition of Na+/K+ ATPase activity, the decrease in sulfhydryl group content and the production of TBARS and MDA. These results suggest that ascorbic acid in the presence of contaminant ferrous ions induced a decrease in functional DA transporters, probably through a lipid peroxidation process involving oxidation of sulfhydryl groups and at least in part through a decrease of Na+/K+ ATPase activity.


Subject(s)
Ascorbic Acid/pharmacology , Dopamine/metabolism , Lipid Peroxidation/drug effects , Synaptosomes/drug effects , Animals , Biological Transport , Chromans/pharmacology , Corpus Striatum/metabolism , Malondialdehyde/metabolism , Oxidation-Reduction , Proteins/metabolism , Rats , Rats, Wistar , Sodium-Potassium-Exchanging ATPase/metabolism , Sulfhydryl Compounds/metabolism , Synaptosomes/metabolism , Thiobarbituric Acid Reactive Substances/metabolism , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...